Abstract
Both 17β-estradiol (17β) and the vitamin D metabolites, 1,25-(OH)2D3 (1,25) and 24,25-(OH)2D3 (24,25), regulate endochondral bone formation in vivo and in vitro. The effects of 17β are sex-specific and cell maturation-dependent. Similarly, the effects of 1,25 and 24,25 are cell maturation-dependent, with 1,25 affecting growth zone chondrocytes (GC) and 24,25 affecting resting zone chondrocytes (RC). This study examined whether the response of chondrocytes to 17β is altered after pretreatment with 1,25 or 24,25. Cells were isolated from the costochondral cartilage of male or female rats. Confluent, fourth-passage GC and RC cultures were pretreated with 1,25 or 24,25, respectively, for 24 or 48 h followed by treatment with 17β for an additional 24 h. At harvest, cell proliferation ([3H]-thymidine incorporation), differentiation (alkaline phosphatase specific activity [ALPase]), general metabolism ([3H]-uridine incorporation), and proteoglycan production ([35S]-sulfate incorporation) were determined. 1,25 enhanced the inhibitory effect of 17β on [3H]-thymidine incorporation by female GC cells; in contrast, no effect was observed in GC cells obtained from male rats. When male RC cells were treated with 17β, [3H]-thymidine incorporation was inhibited; however, when these cells were pretreated with 24,25 for 48 h, 17β stimulated [3H]-thymidine incorporation 24,25 had no effect on 17β-dependent [3H]-thymidine incorporation by female RC cells. 17β stimulated ALPase in female GC cells, but had no effect on male GC cells. 1,25 pretreatment of female GC cells inhibited the stimulatory effect of 17β on ALPase, but had no effect on ALPase in male GC cultures. 17β had no effect on male RC cell ALPase and stimulated ALPase in female RC cells. This was not affected by pretreatment with 24,25. Pretreatment with 1,25 increased the basal level of sulfate incorporation only in female GC. No effect was found in RC cells. These results indicate that pretreatment of rat costochondral chondrocytes with vitamin D metabolites modulate the effect of 17β. Although the effect of vitamin D metabolites alone on these chondrocytes is maturation-dependent and not sex-specific, the influence of preincubation with vitamin D metabolites on the effect of 17β is hormone-specific, sex-specific, and maturation-dependent.
Similar content being viewed by others
References
Frantz, A. G. and Rabkin, M. T. (1965).J. Clin. Endocrinol. Metab. 25, 1470–1480.
Parker, M. W., Johanson, A. J., Rogol, A. D., Kaiser, D. L., and Blizzard, R. M. (1984).J. Clin. Endocrinol Metab. 38, 87–90.
Thompson, R. G., Rodriguez, A., Kowarski, A., Midgeon, C. J., and Blizzard, R. M. (1972).J. Clin. Endocrinol. Metab. 35, 334–337.
Gordon, G. S. (1985).Clin. Orthop. Related Res. 200, 174–180.
Arnett, T. R., Horton, M. A., Colston, K. W., Fraser, D. I., Taylor, L., King, R. J. B., and Stevenson, J. C. (1987). In:Osteoporosis. Christiansen, C., Johansen, J. S., and Riis, B. J. (eds). Osteopress: Copenhagen, pp. 519–538.
Gray, T. K., Flynn, T. C., Gray, K. M., and Nabell, L. M. (1987).Proc. Natl. Acad. Sci. USA 84, 6267–6271.
Gray, T. K., Korach, K., Nabell, L. M., Flynn, T. C., Gray, K. M., Dodd, R. C., Sivam, G., Williams, M. F., and Cohen, M. S. (1987). In:Osteoporosis. Christiansen, C., Johansen, J. S., and Riis, B. J. (eds). Osteopress: Copenhagen, pp. 513–518.
Gray, T. K., Lipes, B., Linkhart, T., Mohan, S., and Baylink, D. (1989).Connect Tissue Res. 20, 23–32.
Ross, J. L., Cassorla, F. G., Skerda, M. C., Valk, I. M., Loriaux, D. L., and Cutler, G. B., Jr. (1983).N. Engl. J. Med. 309, 1104–1106.
Cassorla, F. G., Skerda, M. C., Valk, I. M., Hung, W., Cutler, G. B., Jr., and Loriaux, D. L. (1984).J. Clin. Endocrinol. Metab. 58, 717–720.
Herbai, G. (1971).Acta Physiol. Scand. 83, 77–90.
Corvol, M. T., Malemud, C. J., and Sokoloff, L. (1972).Endocrinology 90, 262–271.
Scranton, P. E., Jr., McMaster, J. H., and Diamond, P. E. (1975).Clin. Orthop. Related Res. 112, 340–348.
Takahashi, M. M. and Noumura, T. (1987).Dev. Biol. 121, 417–422.
Nasatzky, E., Schwartz, Z., Boyan, B. D., Soskolne, W. A., and Ornoy, A. (1993).J. Cell. Physiol. 154, 359–367.
Carrascosa, A., Corvol, M. T., Tsagris, L., and Rappaport, R. [Abstract]. (1981).Pediatr. Res. 25, 1542.
Corvol, M. T., Carrascosa, A., Tsagris, L., Blanchard, O., and Rappaport, R. (1987).Endocrinology 120, 1422–1429.
Blanchard, O., Tsagris, L., Rappaport, R., Duval-Beaupere, G., and Corvol, M. T. (1991).J. Steroid Biochem. Mol. Biol. 40, 711–716.
Nasatzky, E., Schwartz, Z., Soskolne, W. A., Brooks, B. P., Dean, D. D., Boyan, B. D., and Ornoy, A. (1994).Endocr. J. 2, 207–215.
Schwartz, Z., Gates, P. A., Nasatzky, E., Sylvia, V. L., Mendez, J., Dean, D. D., and Boyan, B. D. (1996).Biochim. Biophys. Acta. 1282, 1–10.
Somjen, D., Weisman, Y., Harell, A., Berger, E., and Kaye, A. M. (1989).Proc. Natl. Acad. Sci. USA 86, 3361–3365.
Nasatzky, E., Schwartz, Z., Soskolne, W. A., Brooks, B. P., Dean, D. D., Boyan, B. D., and Ornoy, A. (1994).Connect Tissue Res. 30, 277–294.
Schwartz, Z., Soskolne, W. A., Neubauer, T., Goldstein, M., Adi, S., and Ornoy, A. (1991).Endocrinology 129, 1167–1174.
Ornoy, A., Giron, S., Aner, R., Goldstein, M., Boyan, B. D., and Schwartz, Z. (1994).Bone Miner. 24, 43–58.
Moritake, S., Yamamuro, T., and Yamada, J. (1986).Acta Orthop. Scand. 57, 62–66.
Milam, S. B., Aufdemorte, T. B., Sheridan, P. J., Triplett, R. G., Van Sickels, V. E., and Holt, G. R. (1987).Oral Surg. Med. Oral Pathol. 64, 527–532.
Somjen, D., Kaye, A. M., Harell, A., and Weisman, Y. (1989).Endocrinology 125, 1870–1876.
Young, P. C. and Stack, M. T. (1982).Arthritis Rheum. 25, 568–573.
Rosner, I. A., Mannt, A., Malemud, C. J., Goea, B., and Moskowitz, R. W. (1982).Biochem. Biophys. Res. Commun. 106, 1378–1382.
Dayani, N., Corvol, M. T., Robel, P., Eychenne, B., Moncharmont, B., Tsagris, L., and Rappaport, R. (1988).J. Steroid Biochem. 31, 351–356.
Tsai, C. L. and Lio, T. K. (1992).Life Sci. 50, 1727–1735.
Sheridan, P. J., Aufdemorte, T. B., Holt, G. R., and Gates, G. A. (1985).Rheumatol. Int. 5, 279–281.
Pinus, H., Ornoy, A., Patlas, N., Yaffe, P., and Schwartz, Z. (1993).Connect Tissue Res. 30, 85–98.
Monaghan, B. A., Kaplan, F. S., Lyttle, C. R., Fatton, M. D., Boden, S. D., and Haddad, J. G. (1992).Clin. Orthop. Related Res. 280, 277–280.
Somjen, D., Harell, A., Jaccard, N., Weisman, Y., and Kaye, A. M. (1990).J. Steroid Biochem. Mol. Biol. 37, 491–499.
Kaye, A. M., Weisman, Y., Harell, A., and Somjen, D. (1990).J. Steroid Biochem. Mol. Biol. 37, 431–435.
Bellido, T. and Girasole, G. (1993).Endocrinology 133, 553.
Ornoy, A., Goodwin, D., Noff, D., and Edelstein, S. (1978).Nature 276, 517–520.
Norman, A. W. (1985).Physiologist 28, 219–232.
Garabedian, M., DuBois, M. B., Corvol, M. T., Pezant, E., and Balsan, S. (1978).Endocrinology 102, 1262–1268.
Corvol, M., Ulmann, A., and Garabedian, M. (1980).FEBS Lett. 116, 273–276.
Binderman, I. and Somjen, D. (1984).Endocrinology 115, 430–432.
Fine, N., Binderman, I., Somjen, D., Earon, Y., Edelstein, S., and Weisman, Y. (1985).Bone 6, 99–104.
Somjen, D., Somjen, G. J., Harell, A., Mechanic, G. L., and Binderman, I. (1982).Biochem. Biophys. Res. Commun. 106, 644–651.
Suda, S., Takahashi, N., Shinki, T., Horiuchi, N., Yamaguchi, S., Yoshiki, S., Enomoto, S., and Suda, T. (1985).Calcif. Tissue Int. 37, 82–90.
Balmain, N., Hauchecorne, M., Pike, J. W., Cuisinier-Gleizes, P., and Matlieu, H. (1993).Cell Mol. Biol. 39, 339–350.
Boyan, B. D., Schwartz, Z., Swain, L. D., Carnes, D. L., Jr., and Zislis, T. (1988).Bone 9, 185–194.
Schwartz, Z., Schlader, D. L., Ramirez, V., Kennedy, M. B., and Boyan, B. D. (1989).J. Bone Miner. Res. 4, 199–207.
Schwartz, Z. and Boyan, B. D. (1988).Endocrinology 122, 2191–2198.
Langston, G. G., Swain, L. D., Schwartz, Z., Del Toro F., Gomez, R., and Boyan, B. D. (1990).Calcif. Tissue Int. 47, 230–236.
Sylvia, V. L., Schwartz, Z., Schuman, L., Morgan, R. T., Mackey, S., Gomez, R., and Boyan, B. D. (1993).J. Cell Physiol. 157, 271–278.
Schwartz, Z., Swain, L. D., Kelly, D. W., Brooks, B. P., and Boyan, B. D. (1992).Bone 13, 395–401.
Boyan, B. D., Schwartz, Z., Carnes, D. L., Jr., and Ramirez, V. (1988).Endocrinology 122, 2851–2860.
Schwartz, Z., Dean, D. D., Walton, J. K., Brooks, B. P., and Boyan, B. D. (1995).Endocrinology 136, 402–411.
Arnett, T. R. and Colston, K. W. (1988). [Abstract].J. Bone Miner. Res. 3, S80.
Keeting, P. E., Scott, R. E., Colvard, D. S., Anderson, M. A., Oursler, M. J., Spelsberg, T. C., and Riggs, B. L. (1992).J. Bone Miner. Res. 7, 127–136.
Somjen, D., Weisman, Y., and Kaye, A. M. (1995).J. Steroid Biochem. Mol. Biol. 55, 211–217.
Boyan, B. D., Dean, D. D., Sylvia, V. L., and Schwartz, Z. (1994).J. Cell Biochem. 56, 331–339.
Boyan, B. D., Schwartz, Z., Park-Snyder, S., Dean, D. D., Yang, F., Twardzik, D., and Bonewald, L. F. (1994).J. Biol. Chem. 269, 28,374–28,381.
Dean, D. D., Boyan, B. D., Muniz, O. E., Howell, D. S., and Schwartz, Z. (1996).Calcif. Tissue Int. 59, 109–116.
Schmitz, J. P., Schwartz, Z., Sylvia, V. L., Dean, D. D., Calderon, F., and Boyan, B. D. (1996).J. Cell Physiol. 168, 570–579.
Schwartz, Z., Brooks, B. P., Swain, L. D., Del Toro, F., Norman, A. W., and Boyan, B. D. (1992).Endocrinology 130, 2495–2504.
Schwartz, Z., Hancock, R. H., Dean, D. D., Brooks, B. P., Gomes, R., Boskey, A. L., Balian, G., and Boyan, B. D. (1995).Endocrine 3, 351–360.
Schwartz, Z., Knight, G., Swain, L. D., and Boyan, B. D. (1988).J. Biol. Chem. 263, 6023–6026.
Boyan, B. D., Sylvia, V. L., Dean, D. D., and Scheartz, Z. (1996).Connect Tissue Res. 35, 63–70.
Hale, L. V., Kemick, M. L., and Wuthier, R. E. (1986).J. Bone Miner. Res. 1, 489–495.
Bretaudiere, J. P. and Spillman, T. (1984). InLMethods of Enzymatic Analysis. Bergmeyer, H. U. (ed.), Verlag Chemica: Weinheim, pp. 75–92.
O’Keefe, R. J., Puzas, J. E., Brand, J. S., and Rosier, R. N. (1988).Endocrinology 122, 2953–2961.
Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Rano, R. I. (1951).J. Biol. Chem. 193, 265–275.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schwartz, Z., Finer, Y., Nasatzky, E. et al. The effects of 17\-estradiol on chondrocyte differentiation are modulated by vitamin D3 metabolites. Endocr 7, 209–218 (1997). https://doi.org/10.1007/BF02778143
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02778143